Sep 13, 2018,  by Allianz Partners Business Insights

Heart problems: analysis application developed by Cerner in conjunction with research institute

A new application developed jointly by Cerner and the Duke Clinical Research Institute can gauge certain cardiovascular risks in patients, in particular those related to atherosclerosis. This innovative solution has been developed using SMART and FHIR open-source standards.


A new application developed by Cerner and the Duke Clinical Research Institute has made it possible to evaluate over a 10-year period the risks of developing the cardiovascular disease atherosclerosis.

Based on medical data from the American College of Cardiology and the American Heart Association, the ASCVD Risk Calculator is designed to help doctors diagnose patients and choose the required treatment, according to HealthDataManagement. In particular, it can simulate and compare the levels of risk reduction of different therapies, making them easier to understand for patients.


Two open-source standards used


The Cerner Open Developer Experience is behind the creation of the risk calculator. Developers tested their ideas and prototypes with a range of tools via "sandbox" adapted to SMART (Substitutable Medical Applications and Reusable Technologies) and FHIR (Fast Healthcare Interoperability Resources) standards.

Cerner also gave the researchers access to its Millennium health data archives and its HealtheIntent platform. "This collaboration shows how those involved in the health industry can come together to develop and improve an application that is capable of saving lives using the enormous potential of the SMART and FHIR open-source standards," explains Kevin Shekleton, vice-president of Cerner and a renowned engineer.


Encouraging collaboration


The application was initially developed for Cerner clients but the technology is now free for all to use. "You can use the application with any system that is enabled for SMART for FHIR, Shekleton adds. The Duke Clinical Research Institute is already using it in conjunction with another system devised by a competitor of Cerner, making it "an ideal opportunity to prove by means of this joint venture how open we are".

"We have created this application in such a way that it is capable of compiling large quantities of health data from different sources to obtain a global vision of patients' cases and improve their health," adds Ann Marie Navar, professor of cardiology and a member of the Duke Clinical Research Institute, who shares her partner’s vision. "Cerner’s free-to-access platform encourages collaboration which will facilitate care regardless of the specific platforms used."


Allianz Partners

Linked Topics
About Allianz Partners Business Insights